WHO Links Indian Cough Syrups to Uzbekistan Kids’ Death; Issues Warning

The World Health Organisation (WHO) has cautioned all not to give two cough syrups manufactured by India’s Noida-based company Marion Biotech to children. In a statement WHO said, “Cough syrups made by India’s Marion Biotech should not be used for children after the products were linked to 19 deaths in Uzbekistan.”

“The two products are AMBRONOL syrup and DOK-1 Max syrup. The stated manufacturer of both products is Marion Biotech (Uttar Pradesh, India). Laboratory analysis found both products contained unacceptable amounts of diethylene glycol and /or ethylene,” the WHO statement said.

In December, the health ministry of Uzbekistan alleged that 18 children died in the country after taking medicines from an Indian pharmaceutical company.

The UN health agency added that ‘the substandard products referenced in this alert are unsafe and their use, especially in children, may result in serious injury or death.’

It is for the second time that the WHO to come up with a warning regarding the use of substandard Indian drugs. A Few months back WHO issued an alert for four “contaminated” cough syrups manufactured by an Indian drugmaker, Maiden Pharma. This alert had come following acute kidney injuries and 66 deaths among children in Gambia.

You might also like

Comments are closed.